Skip to content
HowShorted

Monte Rosa Therapeutics, Inc. short interest in 2026

In 2026, Monte Rosa Therapeutics, Inc.'s disclosed short interest ran from 8.53% of shares outstanding on 15 Jan 2026 to 22.58% on 15 Sep 2026, a change of +14.05 percentage points. The year's high was 23.29% on 30 Jun 2026 and its low 8.53% on 15 Jan 2026, averaging 18.10% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.63 days on 15 May 2026. Full history: Monte Rosa Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Monte Rosa Therapeutics, Inc. in 2026

2026 in figures

Start of year
8.53% (15 Jan 2026)
End of year
22.58% (15 Sep 2026)
Change
+14.05 pp
High
23.29% (30 Jun 2026)
Low
8.53% (15 Jan 2026)
Average
18.10%
Highest days to cover
20.63 (15 May 2026)
SEC filings marked
6

Every report in 2026

Monte Rosa Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20268.53%1.37
30 Jan 202611.77%6.73
13 Feb 202614.33%9.28
27 Feb 202615.53%10.70
13 Mar 202613.70%12.64
31 Mar 202616.75%8.8110-K filed, results (8-K)
15 Apr 202619.79%15.99
30 Apr 202618.92%17.85
15 May 202618.70%20.6310-Q filed, results (8-K)
29 May 202620.00%19.21
15 Jun 202621.46%16.62
30 Jun 202623.29%8.49
15 Jul 202621.49%13.08
31 Jul 202619.29%10.59
14 Aug 202620.46%13.9910-Q filed, results (8-K)
31 Aug 202621.19%16.56
15 Sep 202622.58%17.08

See also: Monte Rosa Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.